β-Amyloid-induced IL-1β release from an activated human monocyte cell line is calcium- and G-protein-dependent

Mechanisms of Ageing and Development

Volumn 94, Issue 1-3, 1997, Pages 199-211

  Lorton, Dianne ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

amyloid; Alzheimer's disease; Calcium; Cytokines; G proteins; IL 1 ; Signal transduction

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; AMYLOID BETA PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CHELATING AGENT; CHEMOKINE; CHEMOTACTIC PEPTIDE; CYSTEINE; CYTOKINE; EGTAZIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NICKEL CHLORIDE; PERTUSSIS TOXIN; RECEPTOR;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ALZHEIMER DISEASE; BRAIN; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL LINE; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MICROGLIA; MONOCYTE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SECOND MESSENGER;

AMYLOID BETA-PROTEIN; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL LINE; CULTURE MEDIA; EGTAZIC ACID; GALLIC ACID; GTP-BINDING PROTEINS; HUMANS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MITOGENS; MONOCYTES; NICKEL; PEPTIDE FRAGMENTS; PERTUSSIS TOXIN; VIRULENCE FACTORS, BORDETELLA;

EID: 0030981128     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(96)01847-7     Document Type: Conference Paper

References (50)

1. W.S.T. Griffin, L.C. Stanely, C. Ling, L. White, V. MacLeod, L.J. Perrot, C.L. White, III, and C. Araoz, Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA, 86 (1989) 7611-7615.
2. R. Cacabelos, M. Barquero, P. Garcia, X.A. Alvarez and E. Varela de Seijas, Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders. Methods Find. Exp. Clin. Pharmacol., 13 (1991) 455-458.
3. D.G. Walker, S.U. Kim and P.L. McGeer, Complement and cytokine gene expression in cultured microglial derived from postmortem human brains. J. Neurosci. Res., 40 (1995) 478-493.
4. D. Lorton, J.M. Kocsis, L. King, K. Madden and K.R. Brunden, β-Amyloid peptides induce elevated release of interleukin-1β from activated human monocyte. J. Neuroimmunol., 67 (1996) 21-29.
5. J.B. Davis, G.F. McMurray and D. Schubert, The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochem. Biophy. Res. Commun., 189 (1992) 1096-1100.
6. J. Moss and M. Vaughan, ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins. Adv. Enzymol., 61 (1988) 303-379.
7. P.L. McGeer, J. Rogers and E.G. McGeer, Neuroimmune mechanisms in Alzheimer's disease pathogenesis. Alzheimer Dis. Assoc. Disord., 8 (1994) 149-158.
8. R.E. Mrak, J.G. Sheng and W.S. Griffin, Glial cytokines in Alzheimer's disease: review and pathogenic implications. Human Pathol., 28 (1995) 816-823.
9. D. Lorton and J. Schaller, Is β-amyloid a chemotactic peptide in Alzheimer's disease? Soc. Neurosci., Abstract 22 (1996b) 192.
10. D. Goldgaber, H.W. Harris, T. Hla, T. Maciag, R.J. Donnelly, J.S. Jacobsen, M.P. Vitek and D.C. Gajdusek, Interleukin-1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA, 86 (1989) 7606-7610.
11. P.M. Murphy, The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol., 12 (1994) 593-633.
12. R. Snyderman and R.J. Uhing, Chemoattractant stimulus-response coupling. In J.I. Gallin, I.M. Goldstein and R. Snyderman (eds.), Inflammation: Basic Principles and Clinical Correlates, 2nd edn, Raven, New York, 1992, pp. 421-439.
13. R.W. Kupper, B. Dewald, K.H. Jakobs, M. Baggiolini and P. Gierschik, G-protein activation by IL-8 and related cytokines in human neutrophil plasma membranes. Biochem. J., 282 (1992) 429-434.
14. S. Tsuchiya, M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno and K. Tada, Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer, 26 (1980) 171-176.
15. J. Chin and M.J. Kostura, Dissociation of IL-1β synthesis and secretion in human blood monocytes stimulated with bacterial cell wall products. J. Immunol., 151 (1993) 5574-5585.
16. J. Majde, Ca commercially available serum-free medium appropriate for studies of macrophage functions in vitro. J. Immunol. Methods, 115 (1988) 89-93.
17. J. Yao, L. Harvath, D.L. Gilbert and C.A. Colton Chemotaxis by CNS macrophage, the microglia. J. Neurosci. Res., 27 (1990) 36-42.
18. D.M. Araujo and C.W. Cotman, β-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res., 569 (1992) 141-145.
19. S. Haga, E. Ikeda, M. Sato and T. Ishii, Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res., 601 (1993) 88-94.
20. A. Klegeris, D.G. Walker and P.L. McGeer, Activation of macrophages by Alzheimer β amyloid peptide. Biochem. Biophys. Res. Commun., 199 (1994) 984-991.
21. J. Ghiso, A. Rostagno, J. Gardella, L. Leim, P. Gorevic and B. Frangione, A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion. Biochem. J., 288 (1992) 1053-1059.
22. S.D. Yan, X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroths, D. Stern and A.M. Schmidt, RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature, 382 (1996) 685-691.
23. J. El Khoury, S.E. Hickman, C.A. Thomas, L. Cao, S.C. Silverstein and J.D. Lolke, Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature, 382 (1996) 716-719.
24. K. Boland, M. Behrens, D. Choi, K. Manias and D.H. Perlmutter, The serpin-enzyme complex receptor recognizes soluble, nontoxic Amyloid-β peptide but not aggregated, cytotoxic amyloid-β peptide. J. Biol. Chem., 271 (1996) 18 032-18 044.
25. S.H. Lee, W. Liu, D.W. Dickson, C.F.Brosnan and J.W. Berman, Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1β. J. Immunol., 150 (1993a) 2659-2667.
26. S.H. Lee, W. Liu, P. Roth, D.W. Dickson, J.W. Berman and C.F.Brosnan, Macrophage colony-stimulating factor in human fetal astrocytes and microglia. Differential regulation by cytokines and lipopolysaccharide, and modulation of class II MHC on microglia. J. Immunol., 150 (1993b) 594-604.
27. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell, 52 (1988) 487-501.
28. 2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett., 282 (1991) 127-131.
29. 2-macroglobulin and subacute-phase responses in Alzheimer's disease. Immunol. Today, 14 (1993) 143-144.
30. T.E. Doung, C. Pommier and A.B. Scheibel, Immunodetection of the amyloid P component in Alzheimer's disease. Acta Neuropathol., 78 (1989) 429-437.
31. 1-antichymotrypsin are in the lesions of Alzheimer's disease. Neuroreport, 3 (1992) 201-203.
32. 1-antichymotrypsin mRNA. Am. J. Path., 135 (1989) 827-834.
33. 1-antichymotrypsin in cerebral and systemic amyloid. J. Neuropathol. Exp. Neurol., 49 (1990) 41-48.
34. 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. An immunohistochemical study with monoclonal antibodies against 11 native and inactivated α-antichymotrypsins. Acta Neuropath., (Berl.) 82 (1991) 200-207.
35. 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease. Lab Invest., 66 (1992) 223-229.
36. J. Rogers, L.C. Kirby, S.R. Hempelman, D.L. Berry, P.L. McGeer, A.W. Kaszniak, J. Zalinski, M. Cofield, L. Mansukhani, P. Willson and F. Kogan, Clinical trial of indomethacin in Alzheimer's disease. Neurology, 43 (1993) 1609-1611.
37. K. Andersen, L.J. Launer, A. Ott, A.W. Hoes, M.M.B. Breteler and A. Hofman, Do nonsteroidal antiinflammatory drugs decrease the risk for Alzheimer's disease? Neurology, 45 (1995) 1441-1445.
38. J.C.S. Breitner, B.A. Gau, K.A. Welsh, B.L. Plassman, W.M. McDonald, M.J. Helmas and J.C. Anthony, Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study. Neurology, 44 (1994) 227-232.
39. 2 blocking drugs. Neurobiol. Aging, 16 (1995) 523-530.
40. G.A. Broe, A.S. Henderson, H. Creasey, E. McCusker, H.E. Korten, A.F. Jorm, W. Longley, J.C. Anthony, A case-control study of Alzheimer's disease in Australia. Neurology, 40 (1990) 1698-1707.
41. A.B. Graves, E. White, T.D. Koepsell, B.V. Reifler, G. van Belle, E.B. Larson and M. Raskind, A case-control study of Alzheimer's disease. Ann. Neurol., 28 (1990) 766-774.
42. M.L. Jenkinson, M.R. Bliss, A.T. Brian and D.L. Scott, Rheumatoid arthritis and senile dementia of the Alzheimer's type. Br. J. Rheumatol., 26 (1989) 86-88.
43. G. Li, Y.C. Shen, C.H. Chen, Y.W. Zhau and J.M. Silverman, A case-control study of Alzheimer's disease in China. Neurology, 42 (1992) 1481-1482.
44. U. Lucca, M. Tettamanti, G. Forloni and A. Spagnoli, Nonsteroidal antiinflammatory drug use in Alzheimer's disease. Biol. Psychiatry, 36 (1994) 854-856.
45. P.L. McGeer and F. Rogers, Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology, 42 (1992) 447-449.
46. P.L McGeer, E. McGeer, J. Rogers and J. Sibley, Anti-inflammatory drugs and Alzheimer's disease (letter). Lancet, 335 (1990) 1037.
47. R. Myllykangas-Luosujarvi and H. Isomaki, Alzheimer's disease and rheumatoid arthritis. Br. J. Rheumatol., 33 (1994) 501-502.
48. J.B. Rich, D.X. Rasmusson, M.F. Folstein, K.A. Carson, C. Kawas and J. Brandt, Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology, 45 (1995) 51-55.
49. J. Vane, Towards a better aspirin. Nature, 367 (1994) 215-216.
50. J.A. Mitchell, P. Akarasereenont, C. Thiemermann, R.J. Flower and J.R. Vane, Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA, 90 (1994) 11 693-11 697.